Delivery Order SPE2DB20D1109-SPE2DB23FN70C
- Not listed
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 27, 2021, with a ceiling value of $1,129.45. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 28, 2021. Amerisourcebergen Drug Corp is a...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The fixed-price delivery order has a ceiling value of $1,640.44 and a completion date of January 26, 2023. The award was made on January 25, 2023, and there was no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a key vendor for...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, valued at $1,477.70, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication in 180 ml doses to the Defense Logistics Agency (DLA). The contract, valued at $1,270.30, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 18, 2024. The contract has a completion date of June 20, 2024 and is a firm-fixed price delivery order. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication, with a ceiling value of $2,011.87. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on May 9, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,024.80 and runs through December 10, 2024. This is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The delivery order has a ceiling value of $1,016.24 and a completion date of August 16, 2024. The contract is a firm-fixed-price Delivery Order with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide the...
- This federal contract award is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 120 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., and has a ceiling value of $1,865.62. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,419.60, was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with an ultimate completion date of October 28, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to AmerisourceBergen Drug Corp, has a ceiling value of $1,344.99 and an ultimate completion date of August 22, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. This award is likely part of a larger Indefinite...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN70CDelivery Order
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 9, 2023, with a ceiling value of $2,345.10. The contract has a firm fixed price and is a delivery order with a completion date of March 10, 2023. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that runs through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/9/23 |